Lijing Mao

Title: Lijing Mao: Innovator in Pharmaceutical Composition

Introduction

Lijing Mao is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injection compositions. His work has led to advancements that benefit both the medical community and patients.

Latest Patents

Lijing Mao holds a patent for a nimodipine injection composition and its preparation method. The patent details a composition that includes 0.02-0.23% of nimodipine, 2-30% of oil for injection, 0.8-3% of emulsifier, 0-0.1% of complexing agent, 0-0.3% of stabilizer, and 1-3% of osmotic pressure adjusting agent. Notably, this composition does not contain solubilizers such as ethanol, auxiliary emulsifiers like tween-80, or cosolvents such as benzyl alcohol. This innovative formulation aims to enhance the efficacy and safety of nimodipine injections.

Career Highlights

Throughout his career, Lijing Mao has worked with Jiangsu Jiuxu Pharmaceutical Co., Ltd., where he has contributed to various projects and innovations. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.

Collaborations

Lijing Mao has collaborated with several professionals in his field, including Hong Li and Shan Gao. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Lijing Mao's contributions to the pharmaceutical industry, particularly through his patent for nimodipine injection composition, highlight his role as an innovator. His work continues to impact the field positively, paving the way for future advancements in medical treatments.